NEW YORK, NY – As October arrives, the cultural landscape is typically awash in pink ribbons, signaling the annual observance of Breast Cancer Awareness Month. Yet, for thousands of families, the standard narrative of "early detection" and "beating the cancer" rings hollow. For those living with metastatic breast cancer (MBC)—a terminal diagnosis where the disease has spread to distant organs—the reality is far more complex.
On October 13, National Metastatic Breast Cancer Awareness Day, the organization METAvivor is once again shifting the narrative from passive awareness to urgent action. Through its global initiative, #LightUpMBC, the group will illuminate over 325 landmarks across 20 countries in the distinct colors of MBC awareness: teal, green, and pink. This massive visual demonstration serves as a stark reminder that while early-stage breast cancer may be treatable, Stage 4 remains an incurable, life-altering diagnosis that demands dedicated research funding.
The Reality of Stage 4: Defining the Crisis
Metastatic breast cancer occurs when cancer cells migrate from the breast to vital organs, most commonly the bones, liver, lungs, or brain. Crucially, it remains breast cancer regardless of where it resides in the body; a diagnosis of lung cancer that originated in the breast is still categorized as metastatic breast cancer.
The Myth of the "Cure"
A common misconception in public discourse is that all breast cancer patients eventually become "survivors." For the MBC community, however, treatment is a lifelong commitment. Even when clinical scans show "no evidence of disease" (NED), the cancer is not necessarily gone; it is often merely dormant or suppressed. Because cancer cells frequently develop resistance to existing therapies, patients must endure a constant, exhausting cycle of switching treatments to control the disease’s progression.
The Statistical Weight
The numbers are sobering. In the United States alone, an estimated 42,670 people are projected to die from breast cancer in 2026. This equates to approximately 117 lives lost every single day. These are not merely statistics; they are mothers, fathers, partners, and friends whose lives are being cut short by a disease that currently lacks a cure.
METAvivor, a 501(c)(3) nonprofit, has positioned itself as the only organization in the United States that exclusively funds Stage 4 research. By utilizing a rigorous, dual-track review process—involving both scientific experts and patient advocates—the organization ensures that every dollar donated is funneled into high-impact research aimed at turning this terminal diagnosis into a manageable, chronic condition with a high quality of life.
Chronology of a Movement: From Local Grief to Global Impact
The #LightUpMBC campaign did not begin in a corporate boardroom; it was born from a place of profound personal loss.
- 2017: The movement began with a single act of remembrance when Portsmouth’s Memorial Bridge in New Hampshire was lit in teal, green, and pink to honor those affected by MBC. The effort was spearheaded by Laura Inahara, who sought to honor the memory of her best friend, Jessica Moore, who passed away from the disease at the age of 36.
- 2018–2024: What started as a local tribute rapidly expanded. As word of the campaign spread through social media, communities worldwide began petitioning their local government officials to light bridges, towers, and city halls. The campaign grew from a handful of local structures to an international coalition.
- 2026: Today, the campaign encompasses over 325 landmarks, including iconic structures such as One World Trade Center in New York City, the Willis Tower in Chicago, Philadelphia City Hall, Niagara Falls, the Ness Bridge in Scotland, and the Mactan-Cebu Airport in the Philippines.
The growth of the movement mirrors the increasing visibility of the patient-led advocacy movement. It has successfully raised over $2.7 million for critical research, proving that when patients and their families are given a platform, they can command the attention of world leaders and landmark management alike.
Official Responses and Personal Testimony
The leadership at METAvivor emphasizes that the #LightUpMBC campaign is not just about aesthetics; it is about political and scientific pressure.
Dr. Kelly Shanahan, the Board President of METAvivor, has lived with an MBC diagnosis since 2013. Her survival—now 13 years post-diagnosis—is a testament to the advancements in medical research, but she remains cautious about the future.
"When I was diagnosed with metastatic breast cancer in 2013, I certainly didn’t think I’d still be here 13 years later," Dr. Shanahan remarked. "My hope and the hope of so many others lies in research. METAvivor-funded research is increasingly important these days. #LightUpMBC is the biggest contributor to this research, and it is also a vital way to bring us together as a community."
Laura Inahara, the founder of the campaign, views the lights as a bridge between the living and the lost. "Jessica hoped to illuminate one local landmark. Today, her legacy helps families around the world shine a light for the people they love, teaches patients with MBC how to advocate for themselves, and has raised millions for critical research."
The Main Event: #LightUpMBC Live
On the evening of October 13, the campaign will culminate in #LightUpMBC Live, a digital broadcast designed to bridge the gap between scientific advancement and the human experience.
Broadcast Details
- Time: 8 p.m. ET / 5 p.m. PT
- Hosts: The program will be co-hosted by Tami Eagle Bowling, who has been living with MBC for 11 years, and Broadway performer and breast cancer survivor Kara Lindsay.
- Access: The event will be free to the public, streaming via the METAvivor YouTube channel, Facebook Live, and the LiveOne platform.
A Program of Substance and Art
The broadcast is designed to be more than a fundraiser. It is a masterclass in patient advocacy. Throughout the evening, viewers will be taken on a virtual tour of illuminated landmarks, hearing personal stories from those currently fighting the disease.
Interspersed with these narratives will be segments on the latest scientific breakthroughs, providing a rare look into how laboratory research is being translated into clinical trials. To underscore the emotional weight of the cause, the broadcast will feature performances from world-class artists, including two-time Tony Award winner Victoria Clark, Tony Award nominee Dorian Harewood, actress Christina Bianco, singer-songwriter Cassandra Kubinski, and voiceover artist Tony Daniels.
Implications: Changing the Future of Oncology
The implications of the #LightUpMBC campaign extend far beyond the single night of illumination. By centering the conversation on Stage 4, METAvivor is actively challenging the medical community and the public to reconsider how breast cancer funding is allocated.
Direct Impact on Research
Historically, the vast majority of breast cancer funding has been directed toward early detection and prevention. While these are critical, they provide little solace to the 30% of breast cancer patients who will eventually develop metastasis. METAvivor’s mandate ensures that the most aggressive, most deadly form of the disease finally receives the dedicated financial resources it requires.
Empowering the Patient Voice
The campaign serves as a crucial educational tool. Many patients are diagnosed without a full understanding of their disease or the options available to them. #LightUpMBC provides resources for patients to learn about their subtype, clinical trial participation, and the power of self-advocacy.
Call to Action
The organizers invite the public to participate by photographing their local illuminated landmarks and sharing the images on social media using the hashtags #LightUpMBC and #METAvivor. Every post, every share, and every donation contributes to the goal of transforming a terminal diagnosis into a survivable one.
For those interested in finding a local landmark, viewing the livestream, or making a direct donation to research, the organization maintains a comprehensive portal at www.lightupmbc.org. As the world turns its eyes to the lights on October 13, the message is clear: for those living with metastatic breast cancer, the fight is far from over—and the light of science and community is the only way forward.
About the Author
